Viewing Study NCT06000033


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2025-12-31 @ 4:12 AM
Study NCT ID: NCT06000033
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-08-21
First Post: 2023-08-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Disitamab Vedotin and Anlotinib in Patients With HR-Negative, HER2-Low-Expressing Metastatic Breast Cancer
Sponsor: Qilu Hospital of Shandong University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module